StonvexLoading…
StonvexStonvexStonvexCore line items from COCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $179.76M | $609.78M | $481.99M | $299.68M |
Operating Income | $33.58M | $82.53M | $72.34M | $44.41M |
Net Income | $30.47M | $71.32M | $65.79M | $41.79M |
EPS (Diluted) | $0.50 | $1.19 | $1.10 | $0.70 |
Total Assets | $488.34M | $461.16M | $461.29M | $421.08M |
Total Liabilities | $136.17M | $129.62M | $137.56M | $124.14M |
Cash & Equivalents | $201.91M | $196.87M | $203.71M | $167.04M |
Free Cash Flow OCF − CapEx | $15.14M | $39.02M | $46.15M | $10.50M |
Shares Outstanding | 57.11M | 57.08M | 56.95M | 56.80M |